Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,284
Closed -$124K 795
2019
Q4
$124K Hold
5,284
﹤0.01% 783
2019
Q3
$121K Hold
5,284
﹤0.01% 737
2019
Q2
$135K Sell
5,284
-44,921
-89% -$1.4M ﹤0.01% 803
2019
Q1
$1.82M Buy
50,205
+5,719
+13% +$196K 0.02% 524
2018
Q4
$1.28M Sell
44,486
-5,197
-10% -$224K 0.02% 540
2018
Q3
$3.25M Sell
49,683
-2,166
-4% -$140K 0.04% 405
2018
Q2
$3.38M Sell
51,849
-5,846
-10% -$367K 0.05% 372
2018
Q1
$3.17M Buy
57,695
+7,097
+14% +$421K 0.05% 376
2017
Q4
$3.39M Sell
50,598
-9,640
-16% -$569K 0.06% 345
2017
Q3
$3.54M Sell
60,238
-893
-1% -$43.6K 0.06% 341
2017
Q2
$2.69M Buy
61,131
+4,229
+7% +$219K 0.05% 405
2017
Q1
$3.32M Buy
56,902
+10,898
+24% +$653K 0.06% 345
2016
Q4
$2.7M Sell
46,004
-4,077
-8% -$232K 0.06% 311
2016
Q3
$2.61M Sell
50,081
-6,246
-11% -$280K 0.06% 305
2016
Q2
$2.18M Sell
56,327
-54,011
-49% -$1.98M 0.06% 293
2016
Q1
$3.36M Buy
110,338
+27,721
+34% +$638K 0.08% 251
2015
Q4
$2.09M Buy
82,617
+3,165
+4% +$116K 0.06% 289
2015
Q3
$2.54M Buy
79,452
+17,128
+27% +$656K 0.06% 304
2015
Q2
$3.44M Buy
62,324
+15,949
+34% +$1.01M 0.07% 290
2015
Q1
$2.59M Buy
46,375
+9,821
+27% +$618K 0.05% 355
2014
Q4
$2.55M Buy
+36,554
New +$3.11M 0.05% 327

Other funds holding OVV

Candriam SCA's OVV Position: Q1 2020 in Review

Candriam SCA sold out of Ovintiv (OVV) in Q1 2020, closing a stake of 5,284 shares — an estimated $124K sold.

Candriam SCA first reported a position in OVV in Q4 2014 and held it in 21 quarters. The position peaked at $3.54M in Q3 2017. 276 funds tracked by Wall St. Rank hold OVV as of Q1 2020.

  • Candriam SCA reported no remaining Ovintiv position as of Q1 2020 after selling out during the quarter.
  • Candriam SCA sold 5,284 Ovintiv shares in Q1 2020, an estimated $124K.
  • Candriam SCA first reported a position in Ovintiv in Q4 2014 and held it in 21 quarters.
  • Candriam SCA's Ovintiv position peaked at $3.54M in Q3 2017.
  • 276 funds tracked by Wall St. Rank held Ovintiv as of Q1 2020.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.